The study demonstrates reduced inflammation in LPS-exposed rats treated with Osmanthus fragrans extract, suggesting its potential therapeutic role.
This study investigated the effects of nasal inhalation of Osmanthus fragrans var. aurantiacus (OFA) extract in lipopolysaccharide (LPS)-challenged rats. Electronic nose analysis of the OFA extracts identified 25 volatile organic compounds. Gas chromatography–mass spectrometry–olfactometry (GC–MS–O) analysis revealed that β -ionone, linalool, and related derivatives are the primary odor-active compounds in the OFA extract. LPS exposure increased pro-inflammatory markers like tumor necrosis factor-alpha, caused organ hypertrophy in the liver, lungs, and spleen, and altered transcriptional profiles linked to nuclear factor-kappa B (NF- κ Β) and immune pathways. RNA sequencing of brain tissues showed that while LPS strongly elevated NF- κ Β and cytokine pathways, this effect was less pronounced in OFA-treated rats, indicating reduced LPS-driven inflammation at the transcriptome level. Overall, these findings highlight the potential of OFA extract, abundant in β -ionone and linalool, to mitigate inflammatory signaling and improve select metabolic markers in an LPS-induced inflammatory model.
No takes yet. Share an insight, caveat, or question.
Youn et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: